Apple Watch Series 6 hands-on: an iterative update, always-on screen is very bright and is the best feature, but blood oxygen monitor gave a few failed readings
Also a very red smartwatch — I've had just under 24 hours with the new Apple Watch Series 6, which is just enough time to gather a handful of impressions.
Context & Ripple Effects
This hands-on lands a day after Apple's $399 Series 6 debut in red and graphite, and it extends a verdict The Verge has now reached three years running: after the Series 5 review crowned the always-on display as the headline change, Series 6's brightest feature is again the screen, not a new capability.
That matters because the one genuinely new hardware addition this year — the blood oxygen sensor — is exactly the kind of health feature Apple has leaned on to justify annual upgrades, and early impressions show it failing to deliver readings reliably.
First-order effects
- Buyers coming off a Series 4 or 5 get almost no hardware reason to upgrade beyond the brighter always-on panel and the faster chip, leaving the unproven blood oxygen sensor as the only new selling point.
- Early adopters who bought Series 6 specifically for pulse-ox tracking face immediate reliability doubts, since the reviewer logged multiple failed readings within the first day.
Second-order effects
- Unreliable first-party readings undercut the clinical credibility of the sensor at launch, reinforcing what experts already told The Verge: despite clinicians using the watch off-label, it has yet to change patient management or win broad doctor acceptance.
- With the screen once again carrying the pitch, Apple's differentiation problem deepens — the same 'minor update' framing that defined the Series 5 reviews now applies two generations in a row.
Third-order effects
- Health sensors are proving to be fragile differentiators rather than durable moats: the later patent ruling left US units without the blood oxygen feature entirely, and by the Series 10 review Apple had dropped the sensor from its flagship pitch altogether.
- If the pattern holds, the Apple Watch's competitive ground shifts back to display, charging, and ecosystem lock-in — with an estimated 30M users added in 2020 and roughly 35% of US iPhone owners wearing one, Apple can sustain iteration without any single health feature landing.
The trend: Apple Watch annual updates are converging on display and silicon refinements while health-sensor features prove both technically shaky and legally contestable, leaving the platform's moat in ecosystem rather than medical capability.